Risk factors for breast cancer: Epidemiological evidence from Japanese studies

Cancer Science

Volumn 102, Issue 9, 2011, Pages 1607-1614

  Iwasaki, Motoki ^a   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; ESTROGEN; ESTROGEN RECEPTOR BETA; GENISTEIN; ISOFLAVONE; ORAL CONTRACEPTIVE AGENT; POLYPHENOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE 17BETA DEHYDROGENASE; VITAMIN;

ADIPOSE TISSUE; ALCOHOL CONSUMPTION; BODY FAT; BODY HEIGHT; BODY WEIGHT; BREAST CANCER; BREAST FEEDING; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; FAMILY HISTORY; FOOD INTAKE; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; GROUPS BY AGE; HUMAN; IONIZING RADIATION; JAPANESE; LEISURE; LIFESTYLE MODIFICATION; MAMMOGRAPHY; MENARCHE; MENOPAUSE; PARITY; PASSIVE SMOKING; PHYSICAL ACTIVITY; POPULATION; PRIORITY JOURNAL; RADIATION EXPOSURE; REPRODUCTION; REVIEW; RISK ASSESSMENT; SMOKING; SOYBEAN; TEA; VITAMIN SUPPLEMENTATION; WEIGHT CONTROL;

ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; BODY WEIGHT; BREAST NEOPLASMS; FEMALE; HUMANS; LIFE STYLE; MOTOR ACTIVITY; RISK FACTORS; SMOKING;

EID: 80051814108     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01996.x     Document Type: Review

References (76)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon: International Agency for Research on Cancer, 2010. [Cited 14 Apr 2011.] Available from URL.
2. Ferlay J, Parkin DM, Curado MP et al. Cancer Incidence in Five Continents, Volumes I-IX: IARC CancerBase No. 9. Lyon: International Agency for Research on Cancer, 2010. [Cited 14 Apr 2011.] Available from URL.
3. Ferlay J. World Health Organization, Mortality Database. [Cited 7 Jan 2010.] Available from URL.
4. Hirabayashi Y, Zhang M. Comparison of time trends in breast cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols IV-IX. Jpn J Clin Oncol 2009; 39: 411-12.
5. Shin HR, Boniol M, Joubert C et al. Secular trends in breast cancer mortality in five East Asian populations: Hong Kong, Japan, Korea, Singapore and Taiwan. Cancer Sci 2010; 101: 1241-6.
6. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2011; 41: 139-47.
7. Statistics and Information Department. Minister's Secretariat. Ministry of Health, Labor and Welfare. Vital Statistics of Japan. 1958-2005. Tokyo: Health and Welfare Statistics Association.
8. Jatoi I, Miller AB. Why is breast-cancer mortality declining? Lancet Oncol 2003; 4: 251-4.
9. Kumle M. Declining breast cancer incidence and decreased HRT use. Lancet 2008; 372: 608-10.
10. Yoshiike N, Seino F, Tajima S et al. Twenty-year changes in the prevalence of overweight in Japanese adults: the national nutrition survey 1976-95. Obes Rev 2002; 3: 183-90.
11. Nagata C, Matsushita Y, Shimizu H. Prevalence of hormone replacement therapy and user's characteristics: a community survey in Japan. Maturitas 1996; 25: 201-7.
12. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county. Br J Cancer 1991; 63: 963-6.
13. Tsugane S, de Souza JM, Costa ML Jr et al. Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil, 1969-78. Cancer Causes Control 1990; 1: 189-93.
14. Iwasaki M, Mameri CP, Hamada GS, Tsugane S. Secular trends in cancer mortality among Japanese immigrants in the state of Sao Paulo, Brazil, 1979-2001. Eur J Cancer Prev 2008; 17: 1-8.
15. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001; 2: 133-40.
16. Adami HO, Hunter DJ, Trichopolos D (eds). Textbook of Cancer Epidemiology, 2nd edn. New York: Oxford University Press, 2008.
17. Schottenfeld D, Fraumeni JF (eds). Cancer Epidemiology and Prevention, 3rd edn. New York: Oxford University Press, 2006.
18. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94: 606-16.
19. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000; 21: 427-33.
20. Tsugane S, Sobue T. Baseline survey of JPHC study: design and participation rate. Japan public health center-based prospective study on cancer and cardiovascular diseases. J Epidemiol 2001; 11(Suppl): S24-9.
21. Iwasaki M, Hamada GS, Nishimoto IN et al. Dietary isoflavone intake and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Breast Cancer Res Treat 2009; 116: 401-11.
22. Nagata C, Hu YH, Shimizu H. Effects of menstrual and reproductive factors on the risk of breast cancer: meta-analysis of the case-control studies in Japan. Jpn J Cancer Res 1995; 86: 910-15.
23. Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S. Role and impact of menstrual and reproductive factors on breast cancer risk in Japan. Eur J Cancer Prev 2007; 16: 116-23.
24. World Cancer Research Fund and American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007.
25. Yang XR, Chang-Claude J, Goode EL et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 2011; 103: 250-63.
26. Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S. Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol 2007; 17: 304-12.
27. Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 1996; 88: 756-8.
28. Suzuki R, Iwasaki M, Inoue M et al. Body weight at age 20years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status: the Japan public health center-based prospective study. Int J Cancer 2010; DOI: [Epub ahead of print.]
29. Kuriyama S, Tsubono Y, Hozawa A et al. Obesity and risk of cancer in Japan. Int J Cancer 2005; 113: 148-57.
30. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-78.
31. Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status: a meta-analysis. Int J Cancer 2009; 124: 698-712.
32. Monninkhof EM, Elias SG, Vlems FA et al. Physical activity and breast cancer: a systematic review. Epidemiology 2007; 18: 137-57.
33. Hoffman-Goetz L, Apter D, Demark-Wahnefried W, Goran MI, McTiernan A, Reichman ME. Possible mechanisms mediating an association between physical activity and breast cancer. Cancer 1998; 83: 621-8.
34. Suzuki R, Iwasaki M, Yamamoto S et al. Leisure-time physical activity and breast cancer risk defined by estrogen and progesterone receptor status: the Japan public health center-based prospective study. Prev Med 2011; 52: 227-33.
35. Suzuki R, Iwasaki M, Kasuga Y et al. Leisure-time physical activity and breast cancer risk by hormone receptor status: effective life periods and exercise intensity. Cancer Causes Control 2010; 21: 1787-98.
36. Suzuki S, Kojima M, Tokudome S et al. Effect of physical activity on breast cancer risk: findings of the Japan collaborative cohort study. Cancer Epidemiol Biomarkers Prev 2008; 17: 3396-401.
37. Suzuki R, Iwasaki M, Inoue M et al. Alcohol consumption-associated breast cancer incidence and potential effect modifiers: the Japan public health center-based prospective study. Int J Cancer 2010; 127: 685-95.
38. Nagata C, Mizoue T, Tanaka K et al. Alcohol drinking and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2007; 37: 568-74.
39. Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001; 286: 2143-51.
40. Suzuki R, Orsini N, Mignone L, Saji S, Wolk A. Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Int J Cancer 2008; 122: 1832-41.
41. Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 2006; 166: 2395-402.
42. Weiderpass E, Braaten T, Magnusson C et al. A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 1121-7.
43. Ahn J, Schatzkin A, Lacey JV Jr et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 2007; 167: 2091-102.
44. Kawai M, Minami Y, Kuriyama S et al. Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort study. Br J Cancer 2010; 103: 1443-7.
45. Adlercreutz H. Epidemiology of phytoestrogens. Baillieres Clin Endocrinol Metab 1998; 12: 605-23.
46. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 2003; 95: 906-13.
47. Iwasaki M, Inoue M, Otani T et al. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan public health center-based prospective study group. J Clin Oncol 2008; 26: 1677-83.
48. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006; 98: 459-71.
49. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008; 98: 9-14.
50. Limer JL, Speirs V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res 2004; 6: 119-27.
51. Kuiper GG, Lemmen JG, Carlsson B et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-63.
52. Brooks JD, Thompson LU. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 2005; 94: 461-7.
53. Mousavi Y, Adlercreutz H. Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 1993; 58: 301-4.
54. Iwasaki M, Hamada GS, Nishimoto IN et al. Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians. Cancer Sci 2009; 100: 927-33.
55. Iwasaki M, Hamada GS, Nishimoto IN et al. Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Nutr Cancer 2010; 62: 466-75.
56. Nagata C. Factors to consider in the association between soy isoflavone intake and breast cancer risk. J Epidemiol 2010; 20: 83-9.
57. Yang CS, Lambert JD, Sang S. Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch Toxicol 2009; 83: 11-21.
58. Komori A, Yatsunami J, Okabe S et al. Anticarcinogenic activity of green tea polyphenols. Jpn J Clin Oncol 1993; 23: 186-90.
59. Iwasaki M, Inoue M, Sasazuki S et al. Green tea drinking and subsequent risk of breast cancer in a population to based cohort of Japanese women. Breast Cancer Res 2010; 12: R88.
60. Iwasaki M, Inoue M, Sasazuki S et al. Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case-control study. Breast Cancer Res Treat 2010; 124: 827-34.
61. Shrubsole MJ, Lu W, Chen Z et al. Drinking green tea modestly reduces breast cancer risk. J Nutr 2009; 139: 310-16.
62. Zhang M, Holman CD, Huang JP, Xie X. Green tea and the prevention of breast cancer: a case-control study in Southeast China. Carcinogenesis 2007; 28: 1074-8.
63. Wu AH, Yu MC, Tseng CC, Hankin J, Pike MC. Green tea and risk of breast cancer in Asian Americans. Int J Cancer 2003; 106: 574-9.
64. Nagano J, Kono S, Preston DL, Mabuchi K. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 2001; 12: 501-8.
65. Suzuki Y, Tsubono Y, Nakaya N, Koizumi Y, Tsuji I. Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer 2004; 90: 1361-3.
66. Inoue M, Robien K, Wang R, Van Den Berg DJ, Koh WP, Yu MC. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis 2008; 29: 1967-72.
67. Dai Q, Shu XO, Li H et al. Is green tea drinking associated with a later onset of breast cancer? Ann Epidemiol 2010; 20: 74-81.
68. Luo J, Gao YT, Chow WH et al. Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study. Breast Cancer Res Treat 2010; 120: 693-702.
69. Hanaoka T, Yamamoto S, Sobue T, Sasaki S, Tsugane S. Active and passive smoking and breast cancer risk in middle-aged Japanese women. Int J Cancer 2005; 114: 317-22.
70. Nagata C, Mizoue T, Tanaka K et al. Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 2006; 36: 387-94.
71. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 83: Tobacco Smoke and Involuntary Smoking. Lyon: IARC Press, 2004.
72. Collishaw NE, Boyd NF, Cantor KP et al. Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk. Toronto, Canada: Ontario Tobacco Research Unit, OTRU Special Report Series, 2009.
73. Ambrosone CB, Kropp S, Yang J, Yao S, Shields PG, Chang-Claude J. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17: 15-26.
74. Secretan B, Straif K, Baan R et al. A review of human carcinogens. part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10: 1033-4.
75. Miller MD, Marty MA, Broadwin R et al. The association between exposure to environmental tobacco smoke and breast cancer: a review by the California environmental protection agency. Prev Med 2007; 44: 93-106.
76. Pirie K, Beral V, Peto R, Roddam A, Reeves G, Green J. Passive smoking and breast cancer in never smokers: prospective study and meta-analysis. Int J Epidemiol 2008; 37: 1069-79.